DB14807InvestigationalSmall molecule
Demplatin pegraglumer is under investigation in clinical trial NCT02043288 (Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer).
- Also known as
- NC-6004 nanoplatin
- Code names
- NC-6004
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Demplatin pegraglumer, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account